Article
Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian females.
Sexual health - 1 Dec 2020
Subasinghe Asvini K, Wark John D, Phillips Samuel, Cornall Alyssa, Brotherton Julia M L, Garland Suzanne M
Abstract excerpt
Background The prevalence of genital tract vaccine-type human papillomavirus (HPV) is on the decline due to high vaccine uptake through the national HPV immunisation program in Australia. The aim of this study was to investigate HPV vaccine coverage and factors associated with HPV in a vaccine-eligible sample of young Australian females. METHODS: Females aged 16-25 years were recruited into the Young Female...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.